Chemical Compound
Erythromycin A N-oxide
CAS Registry Number
992-65-4
Primary Record
Erythromycin A N-oxide
- In stock
- 563 g
- Purity
- 98.5 %
- CAS
- 992-65-4
Compound Identifiers & Properties
- CAS
- 992-65-4
- PubChem CID
- 88121
- SMILES
- CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)[N+](C)(C)[O-])O)(C)O)C)C)O)(C)O
- Canonical SMILES
- CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H]([N+](C)(C)[O-])[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O
Names & Synonyms
- Erythromycin A N-oxide
- Erythromycin, anhydro-, N-oxide
- Anhydroerythromycin-N-oxide
- Erythromycin, N-oxide
- Erythromycin,N-oxide
- Erythromycin EP Impurity H
- T9KL5GX5WQ
- UNII-T9KL5GX5WQ
- USAF EL-99
- RefChem:1084258
- AC1L3F2E
- AC1Q21XN
- 992-65-4
- DTXSID50213784
- orb1692890
- SCHEMBL14342543
- DTXCID80136275
- LUIPOVCSQJTWHA-RWJQBGPGSA-N
- C37H67NO14
- Erythromycin A N-oxide (>80%)
- KST-1A0237
- CID88121
- ERYTHROMYCIN A 3''-N-OXIDE
- AR-1A4419
- C37-H67-N-O14
- LS-64652
- HY-134095
- ERYTHROMYCIN IMPURITY H [EP IMPURITY]
- Erythromycin EP Impurity HErythromycin A N-oxide
- 63950-90-3
- ERYTHROMYCIN EP IMPURITY H (REFERENCE GRADE)
- (2S,3R,4S,6R)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl]oxy]-3-hydroxy-N,N,6-trimethyloxan-4-amine oxide
- (3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-{[(2s,3r,4s,6r)-4-(dimethylnitroryl)-3-hydroxy-6-methyltetrahydro-2h-pyran-2-yl]oxy}-14-ethyl-7,12,13-trihydroxy-4-{[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione(non-preferred name)
- 6316-09-2
- (2S,3R,4S,6R)-2-(((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclotetradecan-6-yl)oxy)-3-hydroxy-N,N,6-trimethyltetrahydro-2H-pyran-4-amine oxide
- (2S,3R,4S,6R)-2-(((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl)oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl)oxy)-3-hydroxy-N,N,6-trimethyloxan-4-amine oxide
- (2S,3R,4S,6R)-2-{[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-Ethyl-7,12,13-trihydroxy-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-2,10-dioxo-1-oxacyclotetradecan-6-yl]oxy}-3-hydroxy-N,N,6-trimethyloxan-4-amine N-oxide
- Erythromycin, N-oxide; Oxacyclotetradecane, erythromycin deriv.; Erythromycin A N-oxide; (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-a-L-ribo-hexopyranosyl)oxy]-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-ss-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione N-Oxide; Erythromycin A 3''-N-Oxide